<!DOCTYPE html>
<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>High GILT Expression Is Associated with Improved Survival in Metastatic Melanoma Patients Treated with Immune Checkpoint Inhibition.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="High GILT Expression Is Associated with Improved Survival in Metastatic Melanoma Patients Treated with Immune Checkpoint Inhibition." class="clickable-image" src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9100272/bin/cancers-14-02200-g002.jpg"/> </div> <div class="text-side"> <h1>High GILT Expression Is Associated with Improved Survival in Metastatic Melanoma Patients Treated with Immune Checkpoint Inhibition.</h1> <p>Variable GILT protein expression in melanoma cells of metastatic tumor specimens. (a) Representative hematoxylin and eosin (H&amp;E) staining (left panels) and GILT immunohistochemical (IHC) staining of serial sections of metastatic melanoma specimens. Lower magnification (top panels) illustrates GILT staining in a subset of melanoma cells. Higher magnification (bottom panels) illustrates faint GILT staining within melanoma cells and intense GILT staining within antigen presenting cells with a dendritic morphology. Bar = 100 Âµm. (b) Percentage of metastatic melanoma specimens with negative or positive GILT staining in melanoma cells and antigen presenting cells. (c) Intensity of GILT staining within melanoma cells and antigen presenting cells in metastatic melanoma specimens. (d) Distribution of GILT-expressing melanoma cells within the n = 28 specimens with positive GILT staining in melanoma cells.</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/35565329/" target="_blank">35565329</a></p><p>Type: Premalignant/Malignant, Category: Melanocytic</p>
</div> </div></div></body></html>